login
login

Europe Daily Bulletin No. 8127

12 January 2002
Contents Publication in full By article 33 / 41
ECONOMIC INTERPENETRATION / (eu) chemicals

German pharmaceutical company DEGUSSA has sold its gelatine business (turnover EUR 250 million in 2000 with a staff of 1,485) to the Dutch company SOBEL for EUR 265 million in line with their new strategic orientation of its main business activities. DEGUSSA activity in the gelatine sector represents around 18% of world production.

Contents

THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION